跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AKT-100
首页
药物
AKT-100
AKT-100
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Sweet Gum Fruit Extract as a Therapeutic Agent
US 2010189830 A1
申请人: LIU ZHIJUN
优先权: 2008
US
2 件公开
Pyridopyrazine derivatives and their use as signal transduction modulators
EP 1790342 A1
申请人: ZENTARIS GMBH
优先权: 2005
EP
EFFECTIVE TREATMENT OF OVARIAN CANCER USING TRICIRIBINE AND RELATED COMPOUNDS
US 2009239818 A1
申请人: CHENG JIN Q
优先权: 2008
US
Preparation for regulating immune imbalance of diabetic nephropathy and preparation method thereof
CN 114377052 A
申请人: PHARMACY LIMITED COMPANY OF DRUG RES INSTITUTE OF CHONGQING
优先权: 2022
CN
一种云莓均一多糖RCP-90-1及其分离纯化方法和作为抗肿瘤药物的应用
CN 116120475 B
申请人: 哈尔滨商业大学
优先权: 2022
CN
Application of orthosilicic acid in prevention and treatment of femoral head necrosis caused by glucocorticoid
CN 119326787 A
申请人: QILU HOSPITAL SHANDONG UNIV
优先权: 2023
CN
Pharmaceutical composition, pharmaceutical preparation and application
CN 118903173 A
申请人: QINGHUA DEREN XIAN XINGFU PHARMACEUTICAL LTD
优先权: 2024
CN
Application of NP in preparation of senescence type II diabetes mellitus blood sugar regulation preparation
CN 122272759 A
申请人: UNIV GUANGDONG OCEAN
优先权: 2026
CN
药物
反馈